Compliance and Regulatory Updates

FDA Regulatory Update – What Makary’s “New FDA” Means for the Life Sciences Industry

FDA’s Vision for Transparency and Accountability The latest FDA regulatory update is drawing attention across the life sciences and government contracting world. Dr. Marty Makary’s vision of a “New FDA” centers on increasing transparency, streamlining the approval process, and promoting stronger accountability in how medical products reach the market. For contractors tied to federal health…

Decoding the Federal Procurement Process

Decoding the Federal Procurement Process: Timelines, Players, and Hidden Rules

The federal procurement process often feels like a mystery filled with endless timelines, multiple players, and hidden rules. This post breaks it down into manageable steps, explaining how to navigate “hurry up and wait” timelines, understand the roles of contracting officers, program managers, and evaluators, and uncover the unwritten rules that really drive success. With…

OpenAI GPT-5 Launch & Federal Contracting Implications

OpenAI has officially launched GPT-5, its most advanced AI model to date. This is launched with capabilities that surpass previous iterations in clinical reasoning, legal analysis, and multilingual comprehension. The release is already reshaping federal contracting landscapes. Especially in healthcare, defense, and regulatory compliance. Contractors leveraging AI for automation, data synthesis, and decision support must…